The number of people with susceptibility test result for rifampicin in Puerto Rico
Puerto Rico: The number of people with susceptibility test result for rifampicin was 93.33 in 2021. ▬ Flat
Latest (2021)
93.33
Change on year
down 2.4%
World rank
58th
of 146 countries
All-time high
100
in 2018
All-time low
93.33
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Puerto Rico, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Puerto Rico stood at 93.33. That is the lowest value across all 5 years on record.
The figure is down 2.4% on the previous year and down 3.4% over five years.
Puerto Rico ranks 58th of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Puerto Rico, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 96.67 | — |
| 2018 | 100 | +3.4% |
| 2019 | 96.77 | -3.2% |
| 2020 | 95.65 | -1.2% |
| 2021 | 93.33 | -2.4% |
Puerto Rico compared with similar countries
- Puerto Rico's 93.33 is above the median for high income countries, which is 92.6, 1.0× the median. (56 countries reporting)
- Puerto Rico's 93.33 is above the median for Latin America & Caribbean, which is 59.38, 1.6× the median. (21 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 97.81 | 96.67 | 100 | 3 |
| 2020s | 94.49 | 93.33 | 95.65 | 2 |
Countries ranked near Puerto Rico
More health data for Puerto Rico
- Un projection of annual infant deaths, annual growth rate -20 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.45 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 2,519 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Population ages 00-04, female, annual growth rate -0.4804 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0145 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.8484 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0152 units per person (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Puerto Rico?
- The number of people with susceptibility test result for rifampicin in Puerto Rico was 93.33 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Puerto Rico?
- The highest recorded value was 100 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Puerto Rico?
- The lowest recorded value was 93.33 in 2021.
- How does Puerto Rico rank for the number of people with susceptibility test result for rifampicin?
- Puerto Rico ranks 58th out of 146 countries with data for 2021.
- Where does this Puerto Rico data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).